Business Canadian cannabis sales flat for Village Farms in Q4 But overall net income tripled to US$2.1M Nick LabaMarch 1, 2022
Business Dutch investors to buy 90% stake in CannTrust The deal should allow the firm to exit creditor protection and resume public trading Nick LabaFebruary 28, 2022
Business Hexo refreshes board, reaches deal with activist shareholder 7 new board members will stand for election at a meeting March 8 Nick LabaFebruary 22, 2022
Business Annual sales fall 6% to $43.1M for Aleafia The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales Nick LabaFebruary 15, 2022
Business Hexo suggests share consolidation to stay on Nasdaq A special shareholder meeting is slated for March 8 Nick LabaFebruary 15, 2022
Business Flat sales, $75M net loss for Aurora in Q2 With adult-use sales halved from a year ago, the large majority of the firm's sales now come from international medical markets Nick LabaFebruary 10, 2022
Business Neptune reports Q3 revenue up 17% to $18.4M, net loss of $21M Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories Nick LabaFebruary 10, 2022
Business Canopy’s recreational pot sales drop 18% in Q3 But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising Nick LabaFebruary 9, 2022
Business Israel-based InterCure previews record sales of $31M The firm says it commands 30% of the country's medical cannabis market Nick LabaFebruary 8, 2022
Business Nextleaf ups annual sales to $3.4M but cash reserves run low In December, the firm finished a public offering for proceeds of $3.2 million Nick LabaFebruary 3, 2022